Pnc Financial Services Group, Inc. Cabaletta Bio, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 154 shares of CABA stock, worth $287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154
Previous 72
113.89%
Holding current value
$287
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CABA
# of Institutions
99Shares Held
37.8MCall Options Held
154KPut Options Held
192K-
Black Rock Inc. New York, NY4.76MShares$8.89 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.97MShares$7.42 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$6.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$5.32 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$5.16 Million1.29% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $54.3M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...